Search
forResearch 10 of 1000+
- Skin toxicity of anti‐cancer therapy
- Dermatologic Side Effects of Systemic Targeted Anticancer Therapy
- Advances in the Management of Cutaneous Toxicities of Targeted Therapies
- Anti-EGFR mechanism of action: antitumor effect and underlying cause of adverse events.
- Cutaneous Side Effects in Non-Small Cell Lung Cancer Patients Treated with Iressa (ZD1839), an Inhibitor of Epidermal Growth Factor
- Management of Toxicities of Targeted Therapies
- The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma
- Valorization of Hom Thong Banana Peel (Musa sp., AAA Group) as an Anti-Melanogenic Agent Through Inhibition of Pigmentary Genes and Molecular Docking Study
- Neutralization of IL-8 Prevents the Induction of Dermatologic Adverse Events Associated with the Inhibition of Epidermal Growth Factor Receptor
- LAM/TSC Cell Migration to Uterus in an Experimental Model of Lymphangioleiomyomatosis. Regulation by Anti-Epidermal Growth Factor Receptor Antibody and Rapamycin
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →